dc.contributor.author | Cuzick, J | en_US |
dc.contributor.author | Sestak, I | en_US |
dc.contributor.author | Cawthorn, S | en_US |
dc.contributor.author | Hamed, H | en_US |
dc.contributor.author | Holli, K | en_US |
dc.contributor.author | Howell, A | en_US |
dc.contributor.author | Forbes, JF | en_US |
dc.contributor.author | Investigators, IBIS-I | en_US |
dc.date.accessioned | 2015-02-19T14:31:05Z | |
dc.date.issued | 2015-01 | en_US |
dc.identifier.issn | 1470-2045 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/6566 | |
dc.description | © Cuzick et al. Open Access article distributed under the terms of CC BY. | |
dc.description | http://dx.doi.org/10.1016/S1470-2045(14)71171-4 | |
dc.format.extent | 67 - 75 | en_US |
dc.relation.ispartof | LANCET ONCOLOGY | en_US |
dc.title | Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1016/S1470-2045(14)71171-4 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000346912800046&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 1 | en_US |
pubs.notes | No embargo | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 16 | en_US |